News & Updates
Filter by Specialty:
AKI post-AMI tied to more serious kidney outcomes
Patients who develop acute kidney injury (AKI) following an acute myocardial infarction (AMI) have an elevated risk of more serious kidney outcomes including persistent reductions in estimated glomerular filtration rate (eGFR), end-stage renal disease (ESRD), or renal death, according to results of the PARADISE-MI trial.
AKI post-AMI tied to more serious kidney outcomes
19 Nov 2021
No trade-off between bleeding and ischaemic risk with abbreviated DAPT
Stopping dual antiplatelet therapy (DAPT) after 1 month appeared safe in high-bleeding risk (HBR) patients with acute myocardial infarction (MI) who were implanted with a newer coronary stent, a prespecified subanalysis of the MASTER DAPT* trial has shown.
No trade-off between bleeding and ischaemic risk with abbreviated DAPT
19 Nov 2021
Bleeding common after acute coronary syndrome
Acute coronary syndrome often leads to bleeding events, particularly at gastrointestinal sites, a recent study has found. Such complications are more likely to occur among older patients and those with hypertension, heart failure, and low baseline haemoglobin levels.
Bleeding common after acute coronary syndrome
17 Nov 2021
Long-term TAF works against resistant HBV, poses no excess cardiovascular risk
Tenofovir alafenamide (TAF) shows sustained safety and efficacy in heavily pretreated patients with multidrug-resistant hepatitis B virus (HBV) through 3 years of treatment, albeit leading to elevations in cholesterol levels.
